Organigram Holdings Seeks C$500 Million Financing Approval

A potential M&A spree is brewing, though investors could see their shares diluted.

Organigram Holdings Inc. (Nasdaq: OGI) (TSX: OGI) is paving the way to distribute up to C$500 million in securities.

Organigram filed a preliminary short form base shelf prospectus with Canadian securities commissions, the company announced Monday.

Upon approval, Organigram would be authorized to offer a mixture of financial tools, such as common shares and debt securities, over a 25-month period.

The Nasdaq- and TSX-listed cannabis producer also filed a corresponding registration statement with the U.S. Securities and Exchange Commission, which is currently pending approval.

The company noted in the filing that “any additional sale or issuance of Common Shares or other Securities that are convertible or exchangeable into Common Shares” will dilute the voting power and economic interest held by current investors in the company. Additionally, if option holders buy and then sell their stocks, the increased availability could potentially lower the stock’s price.

Expansion updates

Organigram also said in its last earnings release that research and development efforts are seeing gains both from a scientific development standpoint and in terms of revenue-driving commercial capability, creating intellectual property assets that could bring value to an M&A strategy plan.

In May, the company signed an agreement in May to supply medical cannabis to the German market and reported shipments totaling $1.7 million to Australia in the third quarter.

Adam Jackson

Adam Jackson writes about the cannabis industry for the Green Market Report. He previously covered the Missouri Statehouse for the Columbia Missourian and has written for the Missouri Independent. He most recently covered retail, restaurants and other consumer companies for Bloomberg Business News. You can find him on Twitter at @adam_sjackson and email him at

Leave a Reply

Your email address will not be published. Required fields are marked *

Get the latest cannabis news delivered right to your inbox

The Morning Rise

Unpack the industry with the daily cannabis newsletter for business leaders.

 Sign up

About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


Recent Tweets

Get the latest cannabis news delivered right to your inbox

The Morning Rise

Unpack the industry with the daily cannabis newsletter for business leaders.